Trial
NCT06447987
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
Phase ISUSPENDEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Recurrent Acute Lymphoblastic Leukemia
Intervention
Allogeneic Hematopoietic Stem Cell Transplantation
Why stopped
Pending Interim Analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-05